Christopher J. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration. 

Mr. Moreau also has significant experience managing biotechnology research programs, and deep expertise in business development and capital markets, having raised more than $50 million. He has also been featured on numerous business television and social media interviews and is a highly skilled communicator and sought-after speaker, recently appearing as a guest Lecturer for the University of East London, Pharmacology program.